Curate Biosciences Curate Biosciences (formerly known as GPB Scientific) is a company involved in the processing of cells for gene and cell therapies. | Astellas Gene Therapies Astellas Gene Therapies (formerly known as Audentes Therapeutics) is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases. | Orchard Therapeutics Orchard Therapeutics is a biotechnology company, develops and commercializes transformative ex-vivo autologous hematopoietic stem cell gene therapy to restore normal gene function in primary immune deficiencies, metabolic diseases, and hematological disorders. | ||
Founding Date | Founding Date 2002 | Founding Date 2013 | Founding Date 2015 | Founding Date 2015 |
Type | Type Private | Type Subsidiary | Type Public | Type Public |
Tags | ||||
Locations | Locations Carlsbad, US HQ Richmond, US | Locations San Francisco, US HQ | Locations South San Francisco, US HQ | Locations London, GB HQ Boston, US Boston, US Foster City, US Menlo Park, US |
Employees | Employees 340% decrease | Employees 4091% increase | Employees 26146% increase | Employees 166 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 3.8 b | Valuation ($) 380.1 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $330.5m (FY, 2023) | Revenue (est.) $22.7m (FY, 2022) |
Net income | Net income N/A | Net income ($128.8m) (FY, 2018) | Net income ($145.2m) (FY, 2023) | Net income ($150.7m) (FY, 2022) |
Funding | ||||
Total funding raised | Total funding raised $ 31.5m | Total funding raised $ 180m | Total funding raised $ 424.4m | Total funding raised $ 310.7m |